Press release
Artificial Intelligence In Genomics Market 2023-2028 Key Players Analysis, Demands, Trends, Size, Share and Future Outlook
The artificial intelligence (AI) in genomics market is anticipated to grow from an estimated USD 0.5 billion in 2023 to USD 2.0 billion in 2028, at a CAGR of 32.3% during the forecast period. The market has a promising growth potential due to the need to accelerate processes and timeline and reduce drug development and discovery, and improving computing power and declining hardware cost among other factors. However, the lack of curated genomic data and data privacy concerns are expected to limit the growth of this market to a certain extent.Get a FREE Sample Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=4235597
Key players in the Artificial intelligence (AI) in genomics Market
The key players operating in the artificial intelligence (AI) in genomics market include NVIDIA Corporation (US), Microsoft Corporation (US), Google, Inc. (US), Intel Corporation (US), BenevolentAI (UK), SOPHiA GENETICS (Switzerland), Illumina, Inc. (US), Predictive Oncology, Inc. (US), Invitae Corporation (US), Deep Genomics, Inc. (Canada), Fabric Genomics, Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch, Inc. (US), Dante labs (US), Data4Cure (US), PrecisionLife Ltd (UK), Genoox (US), Lifebit (UK), FDNA, Inc. (US), DNAnexus (US), Engine Biosciences (US), Tempus Labs, Inc. (US), Congenica Ltd (England), Emedgene, Inc. (US), and Seragon Pharmaceuticals, Inc. (US).
The artificial intelligence (AI) in genomics market refers to the application of AI technologies and algorithms in the field of genomics, which involves the study of an organism's complete set of genes, known as the genome. AI in genomics aims to leverage computational power and advanced data analytics to enhance the understanding of genomic data, accelerate research, and improve healthcare outcomes.
The intersection of AI and genomics holds great potential for various areas, including personalized medicine, drug discovery, genetic testing, and precision agriculture. AI techniques, such as machine learning, deep learning, and natural language processing, are applied to analyze and interpret genomic data, identify patterns, make predictions, and gain insights that can lead to advancements in medical research and clinical practice.
Several factors contribute to the growth of the AI in genomics market. Firstly, the decreasing cost of genome sequencing has led to an exponential increase in genomic data generation. AI algorithms play a vital role in managing and interpreting this vast amount of data, enabling researchers to extract meaningful information and uncover hidden patterns.
Secondly, AI can assist in the identification of disease-causing genetic variations, providing valuable insights into the development, progression, and treatment of genetic disorders and cancers. AI algorithms can analyze genomic data in combination with clinical and phenotypic information, leading to more accurate diagnoses, personalized treatment plans, and targeted therapies.
Moreover, AI in genomics accelerates the drug discovery process by helping researchers identify potential drug targets, predict drug efficacy, optimize drug design, and repurpose existing drugs for new indications. By leveraging AI, pharmaceutical companies can streamline their research and development efforts, reducing costs and time-to-market for new therapies.
The AI in genomics market includes various stakeholders, such as technology companies, research institutions, pharmaceutical companies, healthcare providers, and genetic testing companies. These organizations develop AI-driven tools, platforms, and software applications tailored for genomics analysis and interpretation.
However, there are challenges in implementing AI in genomics, including the need for large and diverse datasets, data privacy concerns, regulatory considerations, and the interpretability of AI models. Ethical considerations, such as ensuring unbiased and equitable use of AI in genomic research and clinical decision-making, are also crucial.
The AI in genomics market is witnessing significant investment and collaborations between technology and healthcare companies to harness the potential of AI in transforming genomics research and healthcare delivery. Governments and regulatory bodies are also actively involved in shaping the regulatory landscape and fostering the responsible use of AI in genomics.
Direct Purchase of the Global Artificial Intelligence In Genomics Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=4235597
In summary, the AI in genomics market is experiencing rapid growth as AI technologies are applied to analyze and interpret genomic data, driving advancements in personalized medicine, drug discovery, and genetic research. The integration of AI and genomics has the potential to revolutionize healthcare by improving disease understanding, enabling precision treatments, and accelerating the development of innovative therapies.
+ 1 347 333 3771
sales@reportsandreports.com
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Intelligence In Genomics Market 2023-2028 Key Players Analysis, Demands, Trends, Size, Share and Future Outlook here
News-ID: 3055631 • Views: …
More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…

5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…

Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…

Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Genomics
Spatial Genomics & Transcriptomics Market to Witness Huge Growth by Key Players: …
The Spatial Genomics & Transcriptomics market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Spatial Genomics & Transcriptomics report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The Spatial Genomics & Transcriptomics research report also provides…
Spatial Genomics and Transcriptomics Market to Witness Huge Growth by Key Player …
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Spatial Genomics and Transcriptomics market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report.
This…
Artificial Intelligence for Genomics and Personalised Medicine Market 2021-28|| …
An artificial neural network can reveal patterns in huge amounts of gene expression data, and discover groups of disease-related genes. Scientists hope that the new method can eventually be applied within precision medicine and individualized treatment.
Similar to diagnosing a disease using a genomic basis, AI can help identify which genes have been affected by harmful mutations so that they can be targeted in gene therapy. DNA repair after editing is…
Artificial Intelligence In Genomics Market have Huge Growth of CAGR 52% By 2021- …
The recent report on the Artificial Intelligence In Genomics market offers a thorough assessment of the business vertical as well as a comprehensive overview of the industry and its key segments. According to the report, the growing technological developments and research advancements are contributing to the market's expansion. The report provides extensive insight into key market elements such as drivers, restraints, challenges, strategic expansions, market size and share, growth prospects,…
AI in Genomics Market Top Manufacturers 2030 Fabric Genomics Inc., Verge Genomic …
Allied Market Research published a latest report titled, “AI in Genomics Market : Global Opportunity Analysis and Industry Forecast 2020-2027’’.
The market report features the factors and top market trends that fuel the growth of the market.
Avail sample report with Industry Insights @
https://www.alliedmarketresearch.com/request-sample/11921
Frontrunners in the AI in Genomics Market:
The report includes the frontrunners in the market including Fabric Genomics Inc., Verge Genomics, Freenome Holdings, Inc., MolecularMatch Inc. These market…
What's Driving the Spatial Genomics Market Growth? 10x Genomics, S2 Genomics, Na …
This Spatial Genomics Market research document is structured with the most excellent and advanced tools of collecting, recording, estimating and analysing market data. A profound knowledge of industrial unanimity, market trends and incredible techniques give client's an upper hand in the ABC industry. Businesses can effectively use the data, statistics, research, and insights about the market included in this Spatial Genomics Market report to make decisions about business strategies and…